Literature DB >> 1303306

Changes in sarcolemmal proteins in subacute myocardial infarction in the dog.

M Boutjdir1, D Morgenstern, Y Wei, M Restivo, N el Sherif, M A Siddiqui.   

Abstract

Previous studies have shown degradation of cardiac structural proteins and disruption of the sarcolemma as a result of acute myocardial infarction. However, there is no evidence to date on changes in sarcolemmal membrane proteins induced by experimental subacute myocardial infarction. We studied subepicardial layers overlying myocardial infarct 4 days following ligation of the left anterior descending coronary artery in 12 dog hearts. We first demonstrated that this layer provides the anatomic-electrophysiologic substrate for reentrant arrhythmias using activation mapping techniques and histologic correlations. The makeup of membrane proteins was studied using SDS polyacrylamide gel electrophoresis, peptide mapping, and laser densitometry. Sarcolemmal membrane proteins were isolated by ultracentrifugation through a sucrose gradient. We found that a sarcolemmal polypeptide (MW 126,000; n = 12) in the normal tissues has a different mobility than the corresponding protein (MW 124,000; n = 12) of the ischemic tissues although their peptide analysis appeared similar, suggesting that the protein undergoes a post-translational modification. In addition, two proteins (MW 75,000; n = 12 and MW 88,000; n = 12) were present in greater amount in the ischemic than in the control tissues suggesting either acceleration in protein synthesis or slow down of degradation turnover. These results demonstrate that specific changes occur in membrane proteins subjected to ischemic insults which might be responsible for membrane alterations following ischemia and may contribute to the abnormal electrophysiologic properties and arrhythmia seen in vivo at this stage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1303306

Source DB:  PubMed          Journal:  Cell Mol Biol            Impact factor:   1.770


  1 in total

1.  The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs.

Authors:  Panayota Tsibiribi; Cécile Bui-Xuan; Bernard Bui-Xuan; Alain Tabib; Jacques Descotes; Philippe Chevalier; Marie-Claude Gagnieu; Majda Belkhiria; Quadiri Timour
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.